← FDA Drug Approvals (Drugs@FDA)
OLANZAPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2012-09-12
Drug application
- FDA Application #
ANDA200221- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OLANZAPINE
- Generic name
- OLANZAPINE
- Active ingredients
- OLANZAPINE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- JUBILANT GENERICS
- Manufacturer
- Jubilant Cadista Pharmacuticals Inc.
- First approval
- 2012-09-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown